|
Revenue
|
|
|
|
|
|
|
|
|
|
14,383
|
14,461
|
18,344
|
20,028
|
|
Cost of Revenue
|
|
|
|
|
|
|
|
|
|
|
|
5,968
|
6,257
|
|
Gross profit
|
|
|
|
|
|
|
|
|
|
9,164
|
9,269
|
12,376
|
13,771
|
|
Research and development (R&D)
|
|
|
|
|
|
|
|
|
|
1,544
|
1,530
|
1,554
|
1,670
|
|
Selling, general and administrative (SG&A)
|
|
|
|
|
|
|
|
|
|
1,645
|
1,623
|
1,666
|
1,704
|
|
Acquisition charges
|
|
|
|
|
|
|
|
|
|
|
|
142
|
|
|
Restructuring charges/other
|
|
|
|
|
|
|
|
|
|
|
|
|
257
|
|
Operating profit
|
|
|
|
|
|
|
|
|
|
5,723
|
5,894
|
8,960
|
10,140
|
|
Other income (expense), net (OI&E)
|
|
|
|
|
|
|
|
|
|
175
|
313
|
143
|
106
|
|
Interest and debt expense
|
|
|
|
|
|
|
|
|
|
170
|
190
|
184
|
214
|
|
Income before income taxes
|
|
|
|
|
|
|
|
|
|
5,728
|
6,017
|
8,919
|
10,032
|
|
Provision for income taxes
|
|
|
|
|
|
|
|
|
|
711
|
422
|
1,150
|
1,283
|
|
Net income
|
|
|
|
|
|
|
|
|
|
5,017
|
5,595
|
7,769
|
8,749
|
|
Earnings Per Share, Basic
|
|
|
|
|
|
|
|
|
|
5.33
|
6.05
|
8.38
|
9.51
|
|
Earnings Per Share, Diluted
|
|
|
|
|
|
|
|
|
|
5.24
|
5.97
|
8.26
|
9.41
|
|
Basic (in shares)
|
|
|
|
|
|
|
|
|
|
936
|
921
|
923
|
916
|
|
Diluted (in shares)
|
|
|
|
|
|
|
|
|
|
952
|
933
|
936
|
926
|
|
Net income
|
|
|
|
|
|
|
|
|
|
5,017
|
5,595
|
7,769
|
8,749
|
|
Income allocated to RSUs
|
|
|
|
|
|
|
|
|
|
31
|
27
|
33
|
39
|
|
Income allocated to common stock for diluted EPS
|
|
|
|
|
|
|
|
|
|
4,986
|
5,568
|
7,736
|
8,710
|